These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 33331917)

  • 1. Assessment of Plasma Amyloid-β42/40 and Cognitive Decline Among Community-Dwelling Older Adults.
    Giudici KV; de Souto Barreto P; Guyonnet S; Li Y; Bateman RJ; Vellas B;
    JAMA Netw Open; 2020 Dec; 3(12):e2028634. PubMed ID: 33331917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma MCP-1 and changes on cognitive function in community-dwelling older adults.
    Sanchez-Sanchez JL; Giudici KV; Guyonnet S; Delrieu J; Li Y; Bateman RJ; Parini A; Vellas B; de Souto Barreto P;
    Alzheimers Res Ther; 2022 Jan; 14(1):5. PubMed ID: 34996522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective Associations between Plasma Amyloid-Beta 42/40 and Frailty in Community-Dwelling Older Adults.
    Lu WH; Giudici KV; Rolland Y; Guyonnet S; Li Y; Bateman RJ; de Souto Barreto P; Vellas B
    J Prev Alzheimers Dis; 2021; 8(1):41-47. PubMed ID: 33336223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Aβ and neurofilament light chain are associated with cognitive and physical function decline in non-dementia older adults.
    He L; de Souto Barreto P; Aggarwal G; Nguyen AD; Morley JE; Li Y; Bateman RJ; Vellas B;
    Alzheimers Res Ther; 2020 Oct; 12(1):128. PubMed ID: 33032662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: randomized clinical trial.
    Hanson AJ; Bayer-Carter JL; Green PS; Montine TJ; Wilkinson CW; Baker LD; Watson GS; Bonner LM; Callaghan M; Leverenz JB; Tsai E; Postupna N; Zhang J; Lampe J; Craft S
    JAMA Neurol; 2013 Aug; 70(8):972-80. PubMed ID: 23779114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma beta amyloid level and depression in older adults.
    Metti AL; Cauley JA; Newman AB; Ayonayon HN; Barry LC; Kuller LM; Satterfield S; Simonsick EM; Yaffe K
    J Gerontol A Biol Sci Med Sci; 2013 Jan; 68(1):74-9. PubMed ID: 22499763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-year change in plasma amyloid beta levels and late-life cognitive decline.
    Okereke OI; Xia W; Selkoe DJ; Grodstein F
    Arch Neurol; 2009 Oct; 66(10):1247-53. PubMed ID: 19822780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline.
    Yaffe K; Weston A; Graff-Radford NR; Satterfield S; Simonsick EM; Younkin SG; Younkin LH; Kuller L; Ayonayon HN; Ding J; Harris TB
    JAMA; 2011 Jan; 305(3):261-6. PubMed ID: 21245181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma amyloid beta-42 independently predicts both late-onset depression and Alzheimer disease.
    Blasko I; Kemmler G; Jungwirth S; Wichart I; Krampla W; Weissgram S; Jellinger K; Tragl KH; Fischer P
    Am J Geriatr Psychiatry; 2010 Nov; 18(11):973-82. PubMed ID: 20808106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The plasma level of amyloid-β is associated with cognitive decline: a two years follow-up study in Xi'an rural areas].
    Li JY; Gao L; Wei S; Dang LJ; Shang SH; Chen C; Qu QM
    Zhonghua Nei Ke Za Zhi; 2019 Sep; 58(9):656-661. PubMed ID: 31461816
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
    Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
    Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment.
    Insel PS; Hansson O; Mattsson-Carlgren N
    JAMA Neurol; 2021 Feb; 78(2):229-235. PubMed ID: 33044487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography.
    Palmqvist S; Zetterberg H; Blennow K; Vestberg S; Andreasson U; Brooks DJ; Owenius R; Hägerström D; Wollmer P; Minthon L; Hansson O
    JAMA Neurol; 2014 Oct; 71(10):1282-9. PubMed ID: 25155658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma amyloid is associated with the rate of cognitive decline in cognitively normal elderly: the SCIENCe project.
    Verberk IMW; Hendriksen HMA; van Harten AC; Wesselman LMP; Verfaillie SCJ; van den Bosch KA; Slot RER; Prins ND; Scheltens P; Teunissen CE; Van der Flier WM
    Neurobiol Aging; 2020 May; 89():99-107. PubMed ID: 32081465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of Plasma Amyloid-β Level is More Significant in Early Stage of Cognitive Impairment: A Population-Based Cross-Sectional Study.
    Wang J; Qiao F; Shang S; Li P; Chen C; Dang L; Jiang Y; Huo K; Deng M; Wang J; Qu Q
    J Alzheimers Dis; 2018; 64(1):61-69. PubMed ID: 29865072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions Between Weight Loss and Plasma Neurodegenerative Markers for Determining Cognitive Decline Among Community-Dwelling Older Adults.
    Giudici KV; Guyonnet S; Morley JE; Nguyen AD; Aggarwal G; Parini A; Li Y; Bateman RJ; Vellas B; de Souto Barreto P;
    J Gerontol A Biol Sci Med Sci; 2022 Jun; 77(6):1159-1168. PubMed ID: 35034116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Taxonomy of Subjective Cognitive Decline: Proposal and First Clinical Evidence from the Geneva Memory Clinic Cohort.
    Ribaldi F; Palomo R; Altomare D; Scheffler M; Assal F; Ashton NJ; Zetterberg H; Blennow K; Abramowicz M; Garibotto V; Chicherio C; Frisoni GB
    Neurodegener Dis; 2024; 24(1):16-25. PubMed ID: 38763140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease.
    Mehta PD; Pirttilä T; Mehta SP; Sersen EA; Aisen PS; Wisniewski HM
    Arch Neurol; 2000 Jan; 57(1):100-5. PubMed ID: 10634455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression and plasma amyloid beta peptides in the elderly with and without the apolipoprotein E4 allele.
    Sun X; Chiu CC; Liebson E; Crivello NA; Wang L; Claunch J; Folstein M; Rosenberg I; Mwamburi DM; Peter I; Qiu WQ
    Alzheimer Dis Assoc Disord; 2009; 23(3):238-44. PubMed ID: 19812466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.